Changes

no edit summary
Line 93: Line 93:  
|PARP inhibitors (germline)
 
|PARP inhibitors (germline)
 
|-
 
|-
|''[[BRCA1 syndrome|BRCA1]], [[BRCA2 syndrome|BRCA2]]''
+
|''[[BRCA1]], [[BRCA2]]''
 
|1
 
|1
 
|Often hereditary risk; TNBC
 
|Often hereditary risk; TNBC
Line 271: Line 271:  
|TNBC
 
|TNBC
 
|-
 
|-
|''BRCA1''
+
|''[[BRCA1]]''
 
|[[BRCA1 syndrome|BRCA-Related Breast/ Ovarian Cancer Syndrome]]; TNBC
 
|[[BRCA1 syndrome|BRCA-Related Breast/ Ovarian Cancer Syndrome]]; TNBC
 
|-
 
|-
|''BRCA2''
+
|''[[BRCA2]]''
 
|[[BRCA2 syndrome|BRCA-Related Breast/ Ovarian Cancer Syndrome]]; TNBC
 
|[[BRCA2 syndrome|BRCA-Related Breast/ Ovarian Cancer Syndrome]]; TNBC
 
|-
 
|-